Prescription Drug Search
Product Request Form
Alemtuzumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Alemtuzumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about SaveRxCanada.to
List of countries where we can ship Alemtuzumab:
- Algeria
- Antigua and Barbuda
- Bangladesh
- Barbados
- Bolivia
- Bosnia and Herzegovina
- Bulgaria
- Colombia
- Czech Republic
- Greece
- Guadeloupe
- Guatemala
- Hong Kong
- Hungary
- Iceland
- India
- Ireland
- Italy
- Jamaica
- Latvia
- Lebanon
- Malta
- Monaco
- Netherlands
- Netherlands Antilles
- New Zealand
- Nicaragua
- Panama
- Romania
- Saint Lucia
- Saudi Arabia
- Serbia
- South Africa
- Spain
- United Arab Emirates
- United Kingdom, UK
- United States, US
- Uzbekistan
- Venezuela
- Vietnam
Latest news releases on Alemtuzumab:
Alemtuzumab - Wikipedia
Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, ...
Alemtuzumab - pro.medicin.dk – information om medicin
Alemtuzumab er et humaniseret monoklonalt antistof, der produceres ved rekombinant DNA-teknologi, og som genkender og binder sig til et glykoprotein, CD52, der findes ...
Alemtuzumab | Multiple Sclerosis Society UK
Latest research and info on Lemtrada (formerly known as alemtuzumab or Campath 1-H), side effects, how it works and when it's likely to be available.
Alemtuzumab - Drug Information - Chemocare
Alemtuzumab (Campath) chemotherapy side effects, how it's given, how it works, precautions and self care tips in treatment of B-cell chronic lymphocytic leukemia (CLL)
Alemtuzumab (Lemtrada): Indications, Side Effects ...
Easy to read patient leaflet for Alemtuzumab (Lemtrada). Includes indications, proper use, special instructions, precautions, and possible side effects.
LEMTRADA® (alemtuzumab) | Healthcare Professional Site
The official HCP site for LEMTRADA® (alemtuzumab) for relapsing multiple sclerosis (MS). See Important Safety Information, including Boxed WARNING.
Alemtuzumab - National Cancer Institute - Comprehensive ...
This page contains brief information about alemtuzumab and a collection of links to more information about the use of this drug, research results, and ongoing ...
Campath, Lemtrada (alemtuzumab) dosing, indications ...
Medscape - Chronic lymphocytic leukemia and multiple sclerosis dosing for Campath, Lemtrada (alemtuzumab), frequency-based adverse effects, comprehensive interactions ...
European Medicines Agency - Find medicine - Lemtrada
Product details for Lemtrada; Name: Lemtrada: Agency product number: EMEA/H/C/003718: Active substance: alemtuzumab. International non-proprietary name (INN) or ...
Relapsing MS Infusion Treatment | LEMTRADA® (alemtuzumab)
Get to know LEMTRADA. Hear from patients & specialists, find helpful resources & locate MS events near you. Learn more. See risks & benefits.
